SEC Filing Summary: Oculus Innovative Sciences, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by Oculus Innovative Sciences, Inc. on September 9, 2008, covering events occurring on September 4, 2008. The registrant is a Delaware corporation headquartered in Santa Rosa, California. Note: The request metadata references "Sonoma Pharmaceuticals, Inc.," but the filing text explicitly identifies the registrant as "Oculus Innovative Sciences, Inc."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
The primary material change reported is the termination of a material agreement. On September 4, 2008, the Company terminated the employment agreement with Mr. Mike Wokasch, its Chief Operating Officer. The termination became effective on September 5, 2008.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, or specific financial risks. The document strictly reports the departure of a senior officer and the termination of his employment contract. No unusual items or contingencies were disclosed in this text.
Investor Verification Checklist
- Verify the exact terms of the termination agreement with Mr. Mike Wokasch, including any severance or compensation details not listed in this summary.
- Confirm the interim or permanent replacement for the Chief Operating Officer role.
- Review subsequent filings to assess the operational impact of the COO's departure on the Company's business strategy.
- Clarify the relationship between the registrant name "Oculus Innovative Sciences, Inc." and the metadata reference to "Sonoma Pharmaceuticals, Inc."